Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.

Shares of German pharma giant Bayer AG BAYRY gained 6.6% on Jan. 14, following an update by partner Orion, a Finnish ...

The pharmaceuticals and agriculture group Bayer aims to return its pharmaceuticals business to mid-single-digit percentage ...

Secondary US filings for Bayer assets cannot be relied on again to face future patent cliffs, demanding focus on early-stage ...

Vividion Therapeutics Inc.'s founding chemist prevailed Thursday over fraud claims linked to the biotech company’s $2 billion ...

Bayer's transformation focuses on a revitalized portfolio, strong pipeline, and strategic operational changes for sustained ...

Bayer Leverkusen have seen a bid for Abdoul Koné (20) rejected by Stade de Reims, according to a report from L’Équipe. Koné ...

Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental imaging agents and thereby enter the diagnostic tracers development space. | ...

To promote its newly launched nonhormonal menopause drug, Bayer is linking Lynkuet with a familiar face. The Big Pharma has recruited Gabrielle Union-Wade to serve as a celebrity endorser for the ...